The American College of Rheumatology (ACR) 2024 Convergence has just concluded, showcasing significant advancements and ...
Adicet Bio announced the first person with lupus nephritis (LN) has been dosed with ADI-001, an investigational allogeneic gamma delta CAR T cell therapy that targets B cells. The phase 1 study of ADI ...